Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Infez Med ; 29(1): 20-36, 2021 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-33664170

RESUMO

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the causative pathogen for the COVID-19, first emerged in Wuhan, China, in December 2019 and by March 2020, it was declared a pandemic. COVID-19 pandemic has overburdened healthcare systems in most countries and has led to massive economic losses. SARS-CoV-2 transmission typically occurs by respiratory droplets. The average incubation period is 6.4 days and presenting symptoms typically include fever, cough, dyspnea, myalgia or fatigue. While the majority of patients tend to have a mild illness, a minority of patients develop severe hypoxia requiring hospitalization and mechanical ventilation. Management is mostly supportive. However, several direct anti-viral agents, and immunomodulatory therapy with steroids and various cytokine blockers seem promising in early results. However, an effective vaccine has been established, which will help curb the pandemic.


Assuntos
COVID-19 , Saúde Global/estatística & dados numéricos , Pandemias , SARS-CoV-2/patogenicidade , Corticosteroides/uso terapêutico , Microbiologia do Ar , Antivirais/uso terapêutico , COVID-19/complicações , COVID-19/diagnóstico , COVID-19/epidemiologia , COVID-19/terapia , Teste para COVID-19/métodos , Vacinas contra COVID-19/uso terapêutico , Transmissão de Doença Infecciosa , Hospitalização , Humanos , Hipóxia/etiologia , Hipóxia/terapia , Imunização Passiva , Fatores Imunológicos/uso terapêutico , Período de Incubação de Doenças Infecciosas , Prevenção Primária/métodos , Respiração Artificial , SARS-CoV-2/classificação , SARS-CoV-2/genética , Esteroides/uso terapêutico , Avaliação de Sintomas/métodos , Soroterapia para COVID-19
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA